NCT05127200

Brief Summary

Several studies have demonstrated that direct currents delivered through the skin at the level of the lumbar spinal cord can influence spinal cord function. In human volunteers, anodal lumbar transcutaneous spinal direct current stimulation (tsDCS) alters spinal processing of nociceptive inputs. Whether cervical tsDCS is able to do the same is less well known.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 5, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 19, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

May 24, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 5, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 5, 2022

Completed
Last Updated

July 7, 2023

Status Verified

July 1, 2023

Enrollment Period

7 months

First QC Date

October 5, 2021

Last Update Submit

July 6, 2023

Conditions

Keywords

tsDCSnon-invasive neuromodulationhealthy volunteers

Outcome Measures

Primary Outcomes (1)

  • Change in contact-heat evoked potentials amplitude

    N2/P2 amplitude

    Change from Baseline, at 15-minutes after the end of stimulation

Secondary Outcomes (3)

  • Change in intensity of perception to contact-heat nociceptive stimuli

    Change from Baseline, at 15-minutes after the end of stimulation

  • Change in temporal summation of pain

    Change from Baseline, at 15-minutes after the end of stimulation

  • Change in intensity of perception to mechanical pinprick nociceptive stimuli

    Change from Baseline, at 15-minutes after the end of stimulation

Study Arms (2)

Anodal tsDCS (cervical active, lumbar sham)

EXPERIMENTAL

Participants will receive: 1. 20 minutes of 2.5 milliampere (mA) anodal tsDCS at the cervical level. 2. sham tsDCS at the lumbar level.

Device: Starstim (Neuroelectrics)

Anodal tsDCS (cervical sham, lumbar active)

ACTIVE COMPARATOR

Participants will receive: 1. 20 minutes of 2.5 milliampere (mA) anodal tsDCS at the lumbar level. 2. sham tsDCS at the cervical level.

Device: Starstim (Neuroelectrics)

Interventions

Anodal transcutaneous spinal direct current stimulation (a-tsDCS)

Anodal tsDCS (cervical active, lumbar sham)Anodal tsDCS (cervical sham, lumbar active)

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • \- Healthy young adults

You may not qualify if:

  • Known medical conditions (e.g., diabetes, neuropathy, psychiatric disorders, seizure, migraine, pacemaker or other implanted medical devices...)
  • Use of any medication (except contraception)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NOCIONS lab

Brussels, 1200, Belgium

Location

Related Publications (1)

  • Lenoir C, Jankovski A, Mouraux A. Anodal Transcutaneous Spinal Direct Current Stimulation (tsDCS) Selectively Inhibits the Synaptic Efficacy of Nociceptive Transmission at Spinal Cord Level. Neuroscience. 2018 Nov 21;393:150-163. doi: 10.1016/j.neuroscience.2018.10.007. Epub 2018 Oct 12.

    PMID: 30321585BACKGROUND

MeSH Terms

Conditions

Nociceptive Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • André Mouraux, MD, PhD

    Université Catholique de Louvain

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 5, 2021

First Posted

November 19, 2021

Study Start

May 24, 2022

Primary Completion

December 5, 2022

Study Completion

December 5, 2022

Last Updated

July 7, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations